Watching alerts...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MAPS is pivotal to get public acceptance. Bull rush is starting. Keep this locked going to be fun.
I'm not in this but if you all sold when I told you to you could have made money elsewhere. Ken will release a false narrative PR... pump it to recoup. Then he will RS. Mark this post. And that pump won't be enough to get you boys out.
Half a penny at best will be the height.
3 months from now I will be repeating myself that you will continue to lose money and hope on this stock. Ken has no plans. They have tweets pinned from 2015 for gods sake. LOL
FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD for MAPS.. huge for the sector!!!
https://news.lykospbc.com/2024-02-09-Lykos-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-MDMA-Assisted-Therapy-for-PTSD
FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD for MAPS.. huge for the sector!!!
https://news.lykospbc.com/2024-02-09-Lykos-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-MDMA-Assisted-Therapy-for-PTSD
FDA Acceptance and Priority Review of New Drug Application for MDMA-Assisted Therapy for PTSD for MAPS.. huge for the sector!!!
https://news.lykospbc.com/2024-02-09-Lykos-Therapeutics-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-MDMA-Assisted-Therapy-for-PTSD
I made out on the first runs... I am gobbling up this long loading zone. Will be a gangbuster when the top blows off.
It will be an empty promise, nothing substantial, a hoax. Better sell the news when it hits... make this post it will continue to fall into the trips and then RS.
Will you admit I am right 3 months from now... :)
Excellent stair stepping indeed. Lovely.
Nothing says is has to run and a price hike because of an RS is not a run either.
Ken is full of shit and loves your money.
sitting at the 52 week low. LOL
NOW IS THE TIME TO BUY...
Then sell for 100% gain at .0034
Then let her fall again and rinse and repeat. You bag holders are screwed.
Fine but the time to have gotten back in would be here. Not 24, 48, 64 months ago. It's just absurd to see the sheep follow literally nothing. These is no business at all here. 0.
Bone for all the pumping you've done here you surely have a huge bag at this point. Your opinion is that it should run so you can at least lighten your debt. I'm really sorry this company got ya.
Will send higher. Good times!
For 24 months I said sell... LOL!
Schwing!
That was all sells LMFAO
They can run at any given minute for any given reason. Point is to be in right before it happens :)
Great play here! healthy moves back up. Will be a good year for biotechs!
Undervalued biotech here. Super attractive pipeline and enough cash to get them through 2025 into 2026. I see a buyout happening. Get in this one along with ATAI if you are watching this board. Great plays.
This one is one of my favorite holds for a spring bounce. Everything is primed and ready here.
I think all the chatter either way is good at these levels. Let's give them something to talk about... something to figure out :)
I see this having one more good rally. Fits the recent chart patterns.
Good evening Resx! I see this heading toward a dollar through summer and hitting it in the fall. Easy .25-30 in spring. We are very close here with all this good news thats been released. Fins will be amazing!
Adam,,, go put your money elsewhere. This stock will not make you any money.... it will take money from you.
what do you think about this one here?
Delicious. Locked and loaded to move.
Oxetanes in Drug Discovery Campaigns
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544023/
Various drug companies are using this method to create similar structures of medicines to renew patents and keep the functionality of the drug at hand. Again, I am not an expert, but this seems like a viable IP strategy around LSD and one that others have not matched MindMed on from what I can tell.
They are building commercial runway...
There are lots of analogs of LSD and typically they're made by tweaking three different positions on the LSD molecule. 1) the nitrogen on the five-membered ring, 2) the nitrogen in the six-membered ring and the ethyl groups on the amide nitrogen. This patent doesn't stray from this formula (as I saw from skimming the structures) but the specific modifications they make are interesting, like putting in alkynes or oxetanes. They also have some pharmacology data on receptor binding but I can't speak much to that.
Yes. Great company getting built here. Holding a good position. Many catalysts ahead.
This is going to run quite hard when the next fins are released I think. Just so many good things lining up and the company is healthy.
This is going to be a great one!
First of all did you simply ignore what Ken does? I posted recent issues with him. Second, I having a feeling that you made 0.00 on SPZI... You just are using it as an example of what this could be... which STEV will not turn into... I will continue to sit here and watch this suffering because it is amazing how hard headed this board is. STEV at one point in time was a great trade. It will never wake back up and will absolutely go to the trips here very soon.
Lysergic Acid Derivatives With Modified Lsd-like Action
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023250298&_cid=P21-LQSR22-38874-2
Abstract
(EN) A composition of a compound represented generically by FIGURE 1A for use in substance-assisted therapy. A method of changing neurotransmission, by administering a pharmaceutically effective amount of a compound of FIGURE 1A to a mammal, interacting with serotonin 5-HT2A receptors in the mammal, in particular also human beings, and inducing psychoactive effects. A method of treating an individual, by administering a pharmaceutically effective amount of a compound of FIGURE 1A to the individual and treating the individual.
(FR) L'invention concerne une composition d'un composé représenté de manière générale par la FIGURE 1A destinée à être utilisée dans une thérapie assistée par psychotrope. L'invention concerne également une méthode de modification de la neurotransmission, par administration d'une dose pharmaceutiquement efficace d'un composé de la FIGURE 1A à un mammifère, qui interagit avec les récepteurs 5-HT2A de la sérotonine chez le mammifère, et en particulier chez les êtres humains, et induit des effets psychoactifs. L'invention concerne en outre une méthode de traitement d'un individu, par administration d'une dose pharmaceutiquement efficace d'un composé de la FIGURE 1A à l'individu, ainsi que le traitement de l'individu.
Publication Number
WO/2023/250298
Publication Date
28.12.2023
International Application No.
PCT/US2023/068668
International Filing Date
19.06.2023
IPC
A61K 31/48 2006.1 C07D 457/06 2006.1
Applicants
MIND MEDICINE, INC. [US]/[US]
Inventors
TRACHSEL, Daniel
LIECHTI, Matthias Emanuel
LUSTENBERGER, Felix
Agents
KOHN, Kenneth I.
Priority Data
63/353,673 20.06.2022 US
Publication Language
English (en)
Filing Language
English (en)
Designated States
View all
Title
(EN) LYSERGIC ACID DERIVATIVES WITH MODIFIED LSD-LIKE ACTION
(FR) DÉRIVÉS D'ACIDE LYSERGIQUE AYANT UNE ACTION DE TYPE LSD MODIFIÉE
front page image
They are losing it. Mark this post. No one is being pulled from this. :)
It's coming :)
R-MDMA Patent Application Data
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240010628
Abrois probably 99% of the people on this board need this to go back to .02+ to make even. LOL
Float 86,856,772